If Cellceutix can get one of their three potential cash cows to start giving some milk I would love to see them start advancing their Autism Compound KM-391. Perhaps the market would react in a similar fashion to AVXL and their altzheimers drug.

"KM-391 is a novel compound being developed for the treatment of autism. Based on the initial research, we are very encouraged.

Autism is an area where there is a desperate need for new therapies. There are no drugs currently approved to treat the core conditions of autism. Autism affects as many as 1 in 100 births and takes a terrible toll on the families it affects."